Fields »
ABOUT
HELP
BLOG

151 GENES FOUND

Show / hide columns

XML | RDF | TSV | « prev | Page of 4 | next »

Gene

 

 

Gene description

x

 

 

 

 

 

 

 

Tissue

Cell

Pathology

 

 

 

 

IH abundance (Normal Tissue)

x

RNA abundance (Normal Tissue)

x

Subcellular location

x

Prognostic p-value

x

 

RNA tissue category

x

RNA TS

x

RNA TS TPM

x

 

 

 

 

 

 

 

 

 

 

 

 

 

 
DSEDermatan sulfate epimerase
Nucleoplasm
Cytosol		Renal cancer: 1.50e-4
Cervical cancer: 3.36e-4
Ovarian cancer: 6.34e-4
Mixed
ALOX5APArachidonate 5-lipoxygenase-activating protein
Renal cancer: 5.68e-4
Ovarian cancer: 6.44e-4
Expressed in all
KCNS1Potassium voltage-gated channel, modifier subfamily S, member 1
Ovarian cancer: 6.45e-4
Tissue enhancedcerebral cortex:9.3
gallbladder:3.8
seminal vesicle:4.2
PLAC9Placenta-specific 9
Ovarian cancer: 6.60e-4
Tissue enhancedadipose tissue:87.2
SCAF8SR-related CTD-associated factor 8
NucleoplasmOvarian cancer: 6.61e-4
Expressed in all
STAC2SH3 and cysteine rich domain 2
Nucleoplasm
Vesicles		Endometrial cancer: 4.05e-5
Glioma: 5.04e-4
Ovarian cancer: 6.66e-4
Group enriched6breast:31.7
cerebral cortex:30.2
epididymis:14.8
seminal vesicle:35.5
ANKRD13AAnkyrin repeat domain 13A
Plasma membraneHead and neck cancer: 7.70e-6
Ovarian cancer: 6.77e-4
Expressed in all
MAPKBP1Mitogen-activated protein kinase binding protein 1
NucleoliEndometrial cancer: 1.47e-4
Ovarian cancer: 6.80e-4
Mixed
PGAP3Post-GPI attachment to proteins 3
Plasma membrane
Cytosol		Renal cancer: 3.89e-4
Liver cancer: 3.94e-4
Ovarian cancer: 6.82e-4
Expressed in all
KIAA0141KIAA0141
Nucleoplasm
Golgi apparatus		Ovarian cancer: 6.89e-4
Expressed in all
RB1Retinoblastoma 1
NucleoplasmOvarian cancer: 6.92e-4
Expressed in all
TBC1D22ATBC1 domain family, member 22A
Nucleoplasm
Golgi apparatus
Vesicles		Liver cancer: 2.42e-4
Ovarian cancer: 6.94e-4
Expressed in all
SLC9A1Solute carrier family 9, subfamily A (NHE1, cation proton antiporter 1), member 1
Plasma membraneGlioma: 6.32e-4
Ovarian cancer: 7.10e-4
Expressed in all
SPOCK2Sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 2
Nuclear specklesHead and neck cancer: 1.95e-5
Breast cancer: 4.05e-4
Melanoma: 4.72e-4
Ovarian cancer: 7.19e-4
Tissue enhancedcerebral cortex:162.2
lung:128.2
COL8A2Collagen, type VIII, alpha 2
Golgi apparatusRenal cancer: 9.35e-5
Ovarian cancer: 7.26e-4
Head and neck cancer: 9.44e-4
Mixed
CD163CD163 molecule
Plasma membraneOvarian cancer: 7.27e-4
Mixed
SCRN1Secernin 1
CytosolRenal cancer: 1.15e-5
Endometrial cancer: 4.00e-5
Urothelial cancer: 2.60e-4
Ovarian cancer: 7.27e-4
Breast cancer: 8.32e-4
Cervical cancer: 8.46e-4
Tissue enhancedcerebral cortex:172.5
PLXNB2Plexin B2
Stomach cancer: 4.75e-4
Ovarian cancer: 7.37e-4
Expressed in all
WTAPWilms tumor 1 associated protein
Nucleoplasm
Nuclear speckles		Liver cancer: 6.57e-6
Renal cancer: 3.01e-5
Ovarian cancer: 7.51e-4
Expressed in all
MYCV-myc avian myelocytomatosis viral oncogene homolog
NucleoplasmRenal cancer: 5.49e-8
Urothelial cancer: 4.96e-5
Ovarian cancer: 7.52e-4
Expressed in all
UTP14CUTP14, U3 small nucleolar ribonucleoprotein, homolog C (yeast)
Nucleoli
Cytosol		Renal cancer: 1.46e-5
Ovarian cancer: 7.52e-4
Expressed in all
SOCS5Suppressor of cytokine signaling 5
Nucleoplasm
Plasma membrane
Cytosol		Liver cancer: 7.28e-4
Ovarian cancer: 7.53e-4
Expressed in all
TMEM38ATransmembrane protein 38A
NucleusRenal cancer: 2.99e-10
Lung cancer: 2.78e-5
Ovarian cancer: 7.96e-4
Tissue enriched9skeletal muscle:199.8
TSC22D1TSC22 domain family, member 1
Nucleoplasm
Nuclear bodies		Renal cancer: 4.54e-4
Ovarian cancer: 7.97e-4
Expressed in all
DHRS7Dehydrogenase/reductase (SDR family) member 7
Nucleoplasm
Mitochondria		Renal cancer: 1.92e-10
Head and neck cancer: 2.51e-4
Breast cancer: 6.42e-4
Ovarian cancer: 7.99e-4
Expressed in all
PABPC3Poly(A) binding protein, cytoplasmic 3
CytosolOvarian cancer: 8.00e-4
Tissue enriched149testis:60.2
PJA2Praja ring finger 2, E3 ubiquitin protein ligase
Intermediate filamentsOvarian cancer: 8.02e-4
Expressed in all
LMTK2Lemur tyrosine kinase 2
Nuclear speckles
Plasma membrane
Microtubule organizing center
Cytosol		Renal cancer: 1.12e-7
Ovarian cancer: 8.03e-4
Expressed in all
TRPV4Transient receptor potential cation channel, subfamily V, member 4
Renal cancer: 4.12e-5
Ovarian cancer: 8.10e-4
Mixed
ASAP3ArfGAP with SH3 domain, ankyrin repeat and PH domain 3
Nucleoplasm
Vesicles		Renal cancer: 5.12e-5
Lung cancer: 2.80e-4
Endometrial cancer: 5.56e-4
Ovarian cancer: 8.30e-4
Mixed
TMEM119Transmembrane protein 119
Renal cancer: 2.06e-6
Ovarian cancer: 8.37e-4
Mixed
C6orf120Chromosome 6 open reading frame 120
Liver cancer: 9.52e-5
Cervical cancer: 2.26e-4
Ovarian cancer: 8.37e-4
Expressed in all
RAI1Retinoic acid induced 1
NucleoplasmOvarian cancer: 8.47e-4
Expressed in all
WASF2WAS protein family, member 2
Plasma membrane
Cytosol		Liver cancer: 5.29e-8
Ovarian cancer: 8.48e-4
Expressed in all
TRILTLR4 interactor with leucine-rich repeats
Endometrial cancer: 3.23e-4
Ovarian cancer: 8.52e-4
Tissue enhancedcerebral cortex:25.0
PPIP5K1Diphosphoinositol pentakisphosphate kinase 1
CytosolRenal cancer: 7.14e-8
Ovarian cancer: 8.57e-4
Expressed in all
CNNM4Cyclin and CBS domain divalent metal cation transport mediator 4
Plasma membrane
Actin filaments		Ovarian cancer: 8.75e-4
Endometrial cancer: 9.14e-4
Expressed in all
EHD2EH-domain containing 2
Plasma membraneRenal cancer: 3.98e-4
Ovarian cancer: 8.75e-4
Tissue enhancedadipose tissue:208.4
SCNN1ASodium channel, non voltage gated 1 alpha subunit
Renal cancer: 9.21e-8
Pancreatic cancer: 2.30e-4
Ovarian cancer: 8.86e-4
Mixed
SPIDRScaffolding protein involved in DNA repair
NucleoplasmRenal cancer: 2.04e-6
Ovarian cancer: 8.91e-4
Expressed in all
ZC2HC1AZinc finger, C2HC-type containing 1A
Actin filaments
Cytosol		Stomach cancer: 5.85e-4
Ovarian cancer: 9.00e-4
Mixed
MMP14Matrix metallopeptidase 14 (membrane-inserted)
Intermediate filaments
Cytosol		Renal cancer: 1.34e-4
Ovarian cancer: 9.48e-4
Mixed
COG3Component of oligomeric golgi complex 3
Ovarian cancer: 9.53e-4
Expressed in all
FBXL20F-box and leucine-rich repeat protein 20
MicrotubulesOvarian cancer: 9.54e-4
Mixed
C5AR1Complement component 5a receptor 1
Renal cancer: 1.16e-4
Cervical cancer: 4.71e-4
Testis cancer: 7.99e-4
Ovarian cancer: 9.55e-4
Tissue enhancedappendix:123.6
EPHA4EPH receptor A4
Renal cancer: 5.67e-4
Ovarian cancer: 9.56e-4
Tissue enhancedcerebral cortex:41.8
LOXL4Lysyl oxidase-like 4
VesiclesGlioma: 5.36e-4
Ovarian cancer: 9.57e-4
Mixed
NRROSNegative regulator of reactive oxygen species
Ovarian cancer: 9.63e-4
Mixed
WNK1WNK lysine deficient protein kinase 1
CytosolOvarian cancer: 9.67e-4
Expressed in all
PIM3Pim-3 proto-oncogene, serine/threonine kinase
CytosolRenal cancer: 8.09e-4
Ovarian cancer: 9.68e-4
Expressed in all

« prev | Page of 4 | next »

Contact

The Project

The Human Protein Atlas

The Human Protein Atlas project is funded
by the Knut & Alice Wallenberg foundation.